Standards Desk · recorded August 2026
Seller record · telehealth service · henrymeds.com
Henry Meds
A telehealth service selling compounded GLP-1 drugs, hormone therapy and sexual health medications. It publishes a program price list and names no filling pharmacy.
Passes 6 of 8 criteria. Recorded against Standard v1.1, August 2026.
Operating entity Adonis Health, Inc.
Dispositions at a glance
Evidence, criterion by criterion
What was read, where, and on what date, for each disposition in the table above.
S1PASSA licensed healthcare provider reviews the information and recommends treatment if necessary; the clinical services come from a contracted medical group that is not named.Source: henrymeds.com/faq, henrymeds.com/legal/terms-of-service · read August 2026. S2PASSThe order path was walked from the GLP-1 treatment page and stopped at the first intake question, which asks the buyer's weight loss goal.Source: onboard.henrymeds.com/app/guided-wm/weight-goal · read August 2026. S3FAILThe medications are said to be compounded in a 503(A) Compounding Pharmacy or 503(B) Outsourcing Facility, and no facility is named.Source: henrymeds.com/treatments/weight-management/glp-1-weight-management · read August 2026. S4PASSCompounded medications do not undergo pre-market review or an FDA-approval process, printed in the body of the semaglutide treatment page.Source: henrymeds.com/treatments/weight-management/semaglutide · read August 2026. S5FAILNo certificate, lot report or test document appears on the treatment pages, the FAQ, the terms, or among the 34 addresses the sitemap lists.Source: henrymeds.com/sitemap.xml · read August 2026. S6PASSAdonis Health, Inc. at 1111B S Governors Ave, STE 25428, Dover, DE 19904, printed in the terms; the contact page carries only an email address and a telephone number.Source: henrymeds.com/legal/terms-of-service · read August 2026. S7PASSWeekly or biweekly semaglutide injections are printed at 297 dollars per month, and at 1,782 dollars for 6 months as a one-time payment.Source: henrymeds.com/legal/programs · read August 2026. S8PASSNo letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index · read August 2026. Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, phentermine, testosterone therapy, hormone replacement therapy, sexual health medications.
Dispositions recorded against Standard v1.1, August 2026. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.